Portal
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
134 Coolidge Ave, Watertown, Massachuset...Website
portal.bioRevenue
$6.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Portal
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. They are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portals initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeuticsExplore more
Portal Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Portal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Portal had a recent Job posting/layoffs
Product Launch: Get notified when Portal launches new products
Congratulate Masked Content for being promoted to Masked Content at Portal
Earning: See what the market has to say on Portal recently announced quarterly report
Funding: Get notified immidiatlly once Portal has new funding data
Check if Portal has recently received funding, and reach out quickly before it becomes old news!
Check out if Portal is spiking on competitors!
Portal, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Portal
Find more new buyers
Compare Similar Companies to Portal
Compare insights from companies similar to Portal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Portal is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Portal is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Portal.
Portal financials insights
Gather financial insights about Portal, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$5M
Angel/Seed
$7M
2026
Private Equity
$9M
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Funding
Funding
Funding
Funding
Portal News & Media
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #cellengineering--Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced an oversubscribed $7M seed round led by IA Ventures with participation from Pear VC, Undeterred Ventures, Page One VC, IKJ Capital and other current investors. Portal is implementing a simplified approach to intracellular delivery, focused on enabling novel cell engineering and analytical capabilities. The initial product suite for research and clinPortal Biotechnologies and Multiply Labs Announce Partnership to Automate Cell Engineering In Cell Therapy Manufacturing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Multiply Labs and Portal Biotechnologies announced their collaboration today, combining the efficiency of Multiply Labs’ robotic automation with the differentiated cell engineering capabilities of the Portal platform. This collaboration is an important step forward for cell therapy development and manufacturing with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more patients. “Cell tPortal Biotechnologies Inks $5M Pre-Seed Round
CAMBRIDGE, MA, Portal Biotechnologies, a cell engineering platform company, announced a $5M pre-seed round led by Pear VC.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Portal
Sign Up For FreeTo access detailed company insights
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. They are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Porta... Read More
